Cold Genesys Inc - Company Review
Cold Genesys Inc - Company ReviewSummary
Cold Genesys Inc (Cold Genesys) is a bio-pharmaceutical company that focuses on the research, acquisition and development of novel immunotherapies for the treatment of various cancer indications. It offers products such as CG0070, a phase 3 pivotal trial stage candidate for the treatment of non-muscle invasive bladder cancer and clinical stage candidate CG0161 for the treatment of various cancers. Cold Genesys develops its products based on its proprietary oncolytic virus technology. The company’s target therapy areas include muscle invasive bladder cancer (MIBC), non-muscle invasive bladder cancer (NMIBC) and other solid tumors. It operates with phase pivotal trials in patients with non-muscle invasive bladder cancer. Cold Genesys is headquartered in Santa Ana, California, the US.
This comprehensive company report of Cold Genesys Inc provides you with company's businesses and operations information.
The profile contains critical company information including,
- Company Overview - A detailed description of the company's operations and business divisions.
- Major products and services - A list of major products, services and brands of the company.
- Key competitors - A list of key competitors to the company.
- Key employees - A list of the key executives of the company.
- Important locations and subsidiaries - A list and contact details of key locations and subsidiaries of the company.
GlobalData is a one-stop solution for actionable insight into the pharmaceutical and medical device sectors. Together with the best team of researchers, analysts, epidemiologists and consultants, and an unmatched suite of proprietary databases, we provide high-quality, accurate and transparent insight that can help you achieve growth and increase business value.
Our valuable research and consulting solutions ensure you stay at the forefront of the industry by integrating accurate market forecasts and healthcare analytics on the latest trends and developments. Among other benefits, our informed healthcare industry perspectives have assisted businesses based across the pharmaceuticals, biotechnology and medical equipment markets in making strategic decisions that have increased the value of their products and services.
Unfortunately, this report is not available for the investor type or country you selected.
Browse all ResearchPool reportsReport is subscription only.
Thank you, your report is ready.
Thank you, your report is ready.